The clinical utility of a glaucoma polygenic risk score in four population-based European-ancestry cohorts-Reference-Cited by-同舟云学术

The clinical utility of a glaucoma polygenic risk score in four population-based European-ancestry cohorts

Published:2024-08 Issue: Volume: Page:
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

de Vries Victor A.^ORCID,Hanyuda Akiko^ORCID,Vergroesen Joëlle E.^ORCID,Do Ron,Friedman David S.,Kraft Peter^ORCID,Turman Constance^ORCID,Luo Yuyang (Leo)^ORCID,Tran Jessica H.^ORCID,Liefers Bart^ORCID,Wong Sze H.,Lee Rachel H.,Zebardast Nazlee^ORCID,Klaver Caroline C.W.,Segrè Ayellet V.,Pasquale Louis R.^ORCID,Wiggs Janey L.^ORCID,Kang Jae H.^ORCID,Ramdas Wishal D.^ORCID

Funder

Stichting Lijf en Leven

Ministry of Health, Labour and Welfare

Oogfonds

Glaucoma Foundation

Algemene Nederlandse Vereniging ter voorkoming van Blindheid

National Cancer Institute

Landelijke Stichting voor Blinden en Slechtzienden

European Commission

Maine Medical Center

Stichting voor Ooglijders

National Eye Institute

Stichting voor de Blinden

Erasmus Medical Center

Ministry of Education, Youth and Science

Stichting Blindenhulp

Erasmus School of Economics, Erasmus University Rotterdam

Netherlands Organization for International Cooperation in Higher Education

Labroots, Inc.

Research Institute for Gastroenterology and Liver Diseases

Neighbor Up

ZonMw

Nyckelfonden

ACEM Foundation

Research to Prevent Blindness

Publisher

Elsevier BV

Reference31 articles.

1. The number of people with glaucoma worldwide in 2010 and 2020;Quigley;Br J Ophthalmol,2006

2. Incidence of glaucomatous visual field loss after two decades of follow-up: the Rotterdam Study;Springelkamp;Eur J Epidemiol,2017

3. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma;Kass;Arch Ophthalmol,2002

4. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial;Heijl;Arch Ophthalmol,2002

5. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma;Anderson;Am J Ophthalmol,2003